- Palantir Technologies Inc PLTR a secret plan to deepen his relationship with Britain’s National Health Service without public scrutiny.
- Palantir aimed to buy out smaller competitors who already had an existing relationship with the NHS, Bloomberg Reports citing relevant documents.
- Palantir planned to take over small businesses serving the NHS to “gain a lot of ground and break a lot of political opposition”.
- Also read: “Bad times are incredibly good for Palantir”: CEO Alex Karp
- That Appropriate UK takeover targets were those with credible leadership, annual sales of between £5m and £50m and selling software services to the NHS.
- Since 2020, Palantir has bagged over £37million in contracts with the NHS and Department for Health and Social Care, the report said, citing public spend tracker AdviceCloud.
- Key customer NHS has hired Palantir to help with the COVID-19 response and is currently on a £360million tender contract.
- Palantir hopes to deepen its business with a critical client through key recruitment from the NHS and through potential takeovers.
- Palantir has been criticized in countries like the US and UK for providing government agencies with tools that help enable comprehensive surveillance of the population.
- Palantir confirmed winning the NHS deal on merit.
- Recently, Palantir was awarded a $229 million deal to develop and provide artificial intelligence and machine learning capabilities to the Special Forces, Joint Staff and all branches of the company US Forces.
- Price promotion: PLTR shares traded up 0.87% to $8.15 on the last check Friday premarket.
© 2022 Benzinga.de. Benzinga does not provide investment advice. All rights reserved.
